{"version":"1.0","provider_name":"Forbes Belgi\u00eb","provider_url":"https:\/\/www.forbes.be\/nl","author_name":"Elisabeth Clauss","author_url":"https:\/\/www.forbes.be\/nl\/author\/elisabeth-clauss\/","title":"Olivier Legrain: Technologie, filantropie en po\u00ebzie | Forbes Belgi\u00eb","type":"rich","width":600,"height":338,"html":"<blockquote class=\"wp-embedded-content\" data-secret=\"ZJRXBKutWD\"><a href=\"https:\/\/www.forbes.be\/nl\/olivier-legrain-technologie-filantropie-en-poezie\/\">Olivier Legrain: Technologie, filantropie en po\u00ebzie<\/a><\/blockquote><iframe sandbox=\"allow-scripts\" security=\"restricted\" src=\"https:\/\/www.forbes.be\/nl\/olivier-legrain-technologie-filantropie-en-poezie\/embed\/#?secret=ZJRXBKutWD\" width=\"600\" height=\"338\" title=\"&#8220;Olivier Legrain: Technologie, filantropie en po\u00ebzie&#8221; &#8212; Forbes Belgi\u00eb\" data-secret=\"ZJRXBKutWD\" frameborder=\"0\" marginwidth=\"0\" marginheight=\"0\" scrolling=\"no\" class=\"wp-embedded-content\"><\/iframe><script type=\"text\/javascript\">\n\/* <![CDATA[ *\/\n\/*! This file is auto-generated *\/\n!function(d,l){\"use strict\";l.querySelector&&d.addEventListener&&\"undefined\"!=typeof URL&&(d.wp=d.wp||{},d.wp.receiveEmbedMessage||(d.wp.receiveEmbedMessage=function(e){var t=e.data;if((t||t.secret||t.message||t.value)&&!\/[^a-zA-Z0-9]\/.test(t.secret)){for(var s,r,n,a=l.querySelectorAll('iframe[data-secret=\"'+t.secret+'\"]'),o=l.querySelectorAll('blockquote[data-secret=\"'+t.secret+'\"]'),c=new RegExp(\"^https?:$\",\"i\"),i=0;i<o.length;i++)o[i].style.display=\"none\";for(i=0;i<a.length;i++)s=a[i],e.source===s.contentWindow&&(s.removeAttribute(\"style\"),\"height\"===t.message?(1e3<(r=parseInt(t.value,10))?r=1e3:~~r<200&&(r=200),s.height=r):\"link\"===t.message&&(r=new URL(s.getAttribute(\"src\")),n=new URL(t.value),c.test(n.protocol))&&n.host===r.host&&l.activeElement===s&&(d.top.location.href=t.value))}},d.addEventListener(\"message\",d.wp.receiveEmbedMessage,!1),l.addEventListener(\"DOMContentLoaded\",function(){for(var e,t,s=l.querySelectorAll(\"iframe.wp-embedded-content\"),r=0;r<s.length;r++)(t=(e=s[r]).getAttribute(\"data-secret\"))||(t=Math.random().toString(36).substring(2,12),e.src+=\"#?secret=\"+t,e.setAttribute(\"data-secret\",t)),e.contentWindow.postMessage({message:\"ready\",secret:t},\"*\")},!1)))}(window,document);\n\/\/# sourceURL=https:\/\/www.forbes.be\/nl\/wp-includes\/js\/wp-embed.min.js\n\/* ]]> *\/\n<\/script>\n","thumbnail_url":"https:\/\/www.forbes.be\/nl\/wp-content\/uploads\/2025\/08\/les-pavillons-copyright-philippe-degobert-scaled.jpg","thumbnail_width":2560,"thumbnail_height":1339,"description":"Sinds 2012 staat hij aan het hoofd van het Belgische medtechbedrijf IBA. Vorig jaar richtte hij mee Oncia Community op, een stichting die wereldwijd huizen voor integratieve zorg ontwikkelt. Olivier Legrain wordt gedreven door wetenschappelijke overtuiging \u00e9n humanistische betrokkenheid.\u00a0 \u201cDankzij wetenschappelijke en technologische vooruitgang evolueert kanker stilaan naar een chronische aandoening. Dat is vooral zo [&hellip;]"}